Amylx Pharmaceuticals Inc vs Nebius Group NV — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Nebius Group NV trades at $218 (market cap $49.06B). The key difference: Nebius Group NV is far larger — about 18.6× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals.
| AMLX | NBIS | |
|---|---|---|
Market Cap | $2.64B | $49.06B |
Sector | Health | Technology |
52-Week High | $24.19 | $286.69 |
52-Week Low | $7.82 | $64.06 |
Enterprise Value | $2.39B | $49.26B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →